Cheaper flights are fueling a surge in travel demand, just as spring break season ramps up. Recent data from KAYAK shows that ...

Upon exercise of the option and completion of the acquisition, AlphaTON would be entitled to an upfront cash payment at closing, equity consideration representing 10% of the fully diluted equity of ...

A new generation of leaders is emerging from the Army's science and technology ranks. Scientists, engineers, and ...

The SANDF invites young South Africans to apply for the 2027 Military Skills Development System (MSDS) intake. Applications are open from February 16 to March 27, 2026, and must be submitted in person ...

In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD ...

A new publication DOI 10.29026/oes.2026.250031, discusses an integrated metasurface-freeform system enabled multi-focal ...

FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025.

Melissa L. Johnson, MD, is now chief scientific officer while retaining leadership of lung cancer research, and Erika P. Hamilton, MD, is now chief development officer, late phase, while remaining the ...

Optex Systems Holdings, Inc. (Nasdaq:OPXS), a leading manufacturer of precision optical sighting systems for domestic and ...

BOSTON and TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma TM ("Helus") (Nasdaq: HELP) (Cboe CA: HELP), a clinical ...